Jan L. Wahlstrom

CYP2C9 Inhibition: Impact of Probe Selection and Pharmacogenetics on in Vitro Inhibition Profiles

Vikas Kumar, Jan L. Wahlstrom, Dan A. Rock et al. · Drug Metabolism and Disposition · 2006 · 130 citations

Selection of Alternative CYP3A4 Probe Substrates for Clinical Drug Interaction Studies Using In Vitro Data and In Vivo Simulation

R. Foti, Dan A. Rock, Larry C. Wienkers et al. · Drug Metabolism and Disposition · 2010 · 129 citations

Prediction of CYP2D6 Drug Interactions from In Vitro Data: Evidence for Substrate-Dependent Inhibition

Brooke M. VandenBrink, R. Foti, Dan A. Rock et al. · Drug Metabolism and Disposition · 2011 · 77 citations

Detritylation of Ethers Using Iodine−Alcohol Reagents:  An Acid-Catalyzed Reaction

Jan L. Wahlstrom, Robert C. Ronald · The Journal of Organic Chemistry · 1998 · 75 citations

Chemical Engineering, Engineering, Iodine−alcohol Reagents +9

Evaluation of CYP2C8 Inhibition In Vitro: Utility of Montelukast as a Selective CYP2C8 Probe Substrate

Brooke M. VandenBrink, R. Foti, Dan A. Rock et al. · Drug Metabolism and Disposition · 2011 · 71 citations